Covid 19

Registered on ClinicalTrials

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Pharmacological correction of the cognitive status of patients with post -shoe syndrome

Author:
L.V. Chichanovskaya, T.A. Slyusar, Yu.V. Abramenko, T.M. Nekrasova, I.N. Slyusar

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver

The effectiveness of Mexidol Correction in the correction of the post -shoe syndrome in patients with chronic cerebrovascular diseases

Authors:

E.B. Kuznetsova, E.A. Salina, N.S. Kuznetsov

FSBEI in "Saratov State Medical University named after V.I. Razumovsky "Ministry of Health of Russia, Saratov, Russia

Clinical and psychological profile and quality of life of patients with post-shoe syndrome

Authors:
L.V. Chichanovskaya, T.A. Slyusar, Yu.V. Abramenko, T.M. Nekrasova, I.N. Slyusar

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. Rakhimbayeva, Sh.R. Gazieva, M.K. Atyaniyazov, F.Kh. Muratov, D.S. Tolipov, U.D. Shodiev

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Neurological manifestations of post -shoe syndrome

Authors:

P.R. Kamchatnov ¹ , R.A. Cheremin ² , L.A. Scepterova ² , A.V. Chugunov ¹

¹ FBGOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² GBUZ "Center for Pathology of Speech and Neurorebition of the Moscow Department of Health", Moscow, Russia.

Frequent neurological symptoms of Long-Covid and their correction paths

Author

Ostroumova T.M. - Ph.D., assistant department of the department of nervous diseases and neurosurgery of the Institute of Clinical Medicine named after N.V. Sklifosovsky FGAOU in the First MGMU named after THEM. Sechenova of the Ministry of Health of Russia (Sechenov University)

Place of publication:

03.2022

The use of Mexidol in patients with chemical and covid-19

Author:
A.I. Fedin

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Asthenia and cognitive disorders against the background of the transformed infections of the Covid-19: possible correction routes

Author:
Ostroumova T.M.

FGAOU in "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

The possibilities of increasing the effectiveness of patients with chronic brain ischemia against the background of Covid-19

Authors:
V.V. Kovalchuk, I.I. Ershova, N.V. Molodovskaya

St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko ", St. Petersburg, Russia

The role of antioxidant therapy in patients with the new coronavirus infection of the Covid-19 of the Motenza and Severe

Authors:
E.K. Shavarova ^1.2 , E.R. Kazamedov ¹ , M.V. Alekseeva ¹ , L.G. Yezhova ² , railway Cobalava ¹

¹ Russian University of Friendship of Peoples (RUDN), Moscow, Russian Federation;
² City Clinical Hospital named after V.V. Vinogradov Department of Health of the city of Moscow, Moscow, Russian Federation

The role of free-radical oxidation, hypoxia and their correction in the pathogenesis of Covid-19

Author:
A.V. Schulkin, A.A. Filimonova

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia

Antioxidants/Antihyxants-the missing puzzle of effective pathogenetic therapy of patients with Covid-19

Author:
T.A. Voronin

Research Institute of Pharmacology. V.V. Zakusova, Moscow, Russian Federation

Mexidol® is a modern Russian medication widely used in the rehabilitation treatment of patients who have recovered from COVID-19 and are experiencing post-COVID complications. The drug is based on ethylmethylhydroxypyridine succinate, a nootropic with pronounced antioxidant and membrane-stabilizing properties. These properties help protect cells from damage caused by inflammation and oxidative stress following a viral infection.

Post-COVID syndrome is characterized by the prolonged persistence of a variety of symptoms, such as fatigue, memory and concentration impairment, dizziness, and cardiovascular problems. Mexidol improves cerebral circulation and optimizes neuronal activity, significantly alleviating the neurological and cognitive impairments often associated with COVID-19.

The drug also helps normalize metabolic processes by reducing free radical levels and reducing inflammation. This is especially important for patients experiencing chronic fatigue and delayed recovery after coronavirus infection. Thanks to its comprehensive effects, Mexidol supports the restoration of the functional capacity of the nervous system and heart.

Clinical observations indicate that a course of treatment with Mexidol improves patients' quality of life by increasing mental alertness, reducing weakness, and restoring physical endurance. The drug can be used alone or in combination with other treatments for post-COVID syndrome.

Thus, Mexidol® is an effective remedy for comprehensive health restoration and return to active life after coronavirus disease.